
Gujarat Inject Announces Revised Record Date for 10:1 Stock Split Amid Strong Financial Results and Solar Order Wins
Gujarat Inject (Kerala) Limited, a company focused on manufacturing and logistics within India's clean energy ecosystem, has announced a revision to the Record Date for its upcoming stock split. The revised date is set for Wednesday, July 8, 2026, superseding the previously scheduled date of July 2, 2026. This corporate action comes amid the company’s robust financial growth and significant contract wins in the renewable energy sector.The highly anticipated corporate restructuring centers around a 10:1 stock split. The Mechanics of the Split
A stock split involves dividing existing shares into multiple units without altering core market capitalization, providing structural advantages designed to benefit retail investors. Under the 10:1 ratio, ten equity shares will be issued for every one existing share held by shareholders who are recorded as beneficial owners on the revised date of July 8, 2026. The split also adjusts the face value per equity share while enhancing market liquidity and affordability by proportionally scaling down the absolute market price per share.
Financial Highlights and Market Performance
The decision to implement the stock split is supported by the company's stellar financial performance for the fiscal period ended March 2026. Gujarat Inject (Kerala) Limited reported significant year-on-year growth in both net sales and net profit.Key financial metrics are detailed below:
| Financial Metric | Quarter Ended March 2026 | YoY Change (vs. Q1 Mar 2025) | Full Year Ended March 2026 | YoY Change (vs. FY 2025) |
|---|---|---|---|---|
| Net Sales/Revenue | 30.70 Crore | 624.06% (from 4.24 Cr) | 36.32 Crore | 90.66% (from 19.05 Cr) |
| Net Profit (PAT) | 64 Crore | 2,242.86% (from 0.07 Cr) | 81 Crore | 77.45% (from 0.02 Cr) |
In addition to these results, the company reported expanding profit margins, improved return on equity (ROE), zero debt liabilities, and completely unpledged promoter holdings.
Securing Major Solar Contracts
The strategic momentum of Gujarat Inject is further evidenced by a series of multi-million rupee commercial contracts secured in India's solar infrastructure supply chain. These recent operational wins include:- Deon Energy Limited Contract: A purchase order valued at 4.49 Crore (exclusive of GST) to supply and deliver 16,129 units of high-capacity (620 Wp) Solar Photovoltaic (PV) modules.
- Ottire Lifestyle Private Limited Contract: An additional supply contract valued at 0.07 Crore for 1,334 units of specialized 600 Wp solar PV modules.
- Pipeline Scalability Order: A separate solar module order finalized in early June valued at 6.07 Crore.
These contracts bring recent order wins to over 11 Crore, a substantial commercial portfolio compared to the company's previous fiscal size. These developments are occurring during a period when the company is proposing a strategic corporate rebranding to Regenova Renewtech Limited to align its identity with clean energy solutions.
Management Commentary
A spokesperson for Gujarat Inject (Kerala) Limited stated that the upcoming 10:1 sub-division reflects an ongoing effort to enhance market inclusivity. The spokesperson noted that, backed by an extraordinary 2,242% increase in March quarterly net profit and over 11 Crore in recent solar order wins, the company is executing a successful pivot into renewable energy. The management anticipates welcoming a broader public shareholder base into the Gujarat Inject family upon establishing the revised Record Date of July 8, 2026.Stock Price Movement
As of 13:56, shares of Gujarat Inject Kerala Ltd are edging higher, currently trading at ₹134.05, reflecting a 2.41% gain. The stock has maintained volatility throughout the session, moving between an intraday low of ₹132.00 and a high of ₹137.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.